share_log

Piper Sandler Maintains Overweight on Merit Medical Systems, Raises Price Target to $95

Piper Sandler Maintains Overweight on Merit Medical Systems, Raises Price Target to $95

派珀·桑德勒維持對Merit Medical Systems的增持,將目標股價上調至95美元
Benzinga ·  01/12 10:52

Piper Sandler analyst Jason Bednar maintains Merit Medical Systems (NASDAQ:MMSI) with a Overweight and raises the price target from $88 to $95.

派珀·桑德勒分析師傑森·貝德納維持Merit Medical Systems(納斯達克股票代碼:MMSI)的增持,並將目標股價從88美元上調至95美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論